Skip to main content
Top
Published in: Journal of Neurology 10/2014

01-10-2014 | Original Communication

Prior medical conditions and the risk of amyotrophic lateral sclerosis

Authors: Meinie Seelen, Perry T. C. van Doormaal, Anne E. Visser, Mark H. B. Huisman, Margot H. J. Roozekrans, Sonja W. de Jong, Anneke J. van der Kooi, Marianne de Visser, Nicol C. Voermans, Jan H. Veldink, Leonard H. van den Berg

Published in: Journal of Neurology | Issue 10/2014

Login to get access

Abstract

Sporadic amyotrophic lateral sclerosis (ALS) is believed to be a complex disease in which multiple exogenous and genetic factors interact to cause motor neuron degeneration. Elucidating the association between medical conditions prior to the first symptoms of ALS could lend support to the theory that specific subpopulations are at risk of developing ALS and provide new insight into shared pathogenic mechanisms. We performed a population-based case–control study in the Netherlands, including 722 sporadic ALS patients and 2,268 age and gender matched controls. Data on medical conditions and use of medication were obtained through a structured questionnaire. Multivariate analyses showed that hypercholesterolemia (OR 0.76, 95 % CI 0.63–0.92, P = 0.006), the use of statins (OR 0.45, 95 % CI 0.35–0.59, P = 1.86 × 10−9) or immunosuppressive drugs (OR 0.26, 95 % CI 0.08–0.86, P = 0.03) were associated with a decreased risk of ALS. Head trauma was associated with an increased ALS susceptibility (OR 1.95, 95 % CI 1.11–3.43, P = 0.02). No association was found with autoimmune diseases, cancer, psychiatric disorders or cardiovascular diseases, or survival. The lower frequency of hypercholesterolemia and less use of statins in ALS patients indicate a favorable lipid profile prior to symptom onset in at least a subpopulation of ALS. Prior head trauma is a risk factor for ALS and the significantly lower use of immunosuppressive drugs in ALS patients could suggest a protective effect. The identification of specific subpopulations at risk for ALS may provide clues towards possible pathogenic mechanisms.
Appendix
Available only for authorised users
Literature
3.
go back to reference Turner MR, Wotton C, Talbot K, Goldacre MJ (2012) Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry 83:395–398. doi:10.1136/jnnp-2011-301161 CrossRefPubMed Turner MR, Wotton C, Talbot K, Goldacre MJ (2012) Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry 83:395–398. doi:10.​1136/​jnnp-2011-301161 CrossRefPubMed
5.
go back to reference Byrne S, Heverin M, Elamin M et al (2013) Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case–control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol 74:699–708. doi:10.1002/ana.23969 CrossRefPubMed Byrne S, Heverin M, Elamin M et al (2013) Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case–control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol 74:699–708. doi:10.​1002/​ana.​23969 CrossRefPubMed
6.
go back to reference Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U et al (2005) Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol 252:772–781CrossRefPubMed Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U et al (2005) Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol 252:772–781CrossRefPubMed
8.
go back to reference Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ (2010) Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson’s disease: record linkage studies. J Neurol Neurosurg Psychiatry 81:215–221. doi:10.1136/jnnp.2009.175463 CrossRefPubMed Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ (2010) Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson’s disease: record linkage studies. J Neurol Neurosurg Psychiatry 81:215–221. doi:10.​1136/​jnnp.​2009.​175463 CrossRefPubMed
14.
go back to reference Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299CrossRefPubMed Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299CrossRefPubMed
22.
go back to reference Nelson LM, Matkin C, Longstreth WT Jr, McGuire V (2000) Population-based case–control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol 151:164–173CrossRefPubMed Nelson LM, Matkin C, Longstreth WT Jr, McGuire V (2000) Population-based case–control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol 151:164–173CrossRefPubMed
24.
25.
go back to reference Edwards IR, Star K, Kiuru A (2007) Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Drug Saf 30:515–525CrossRefPubMed Edwards IR, Star K, Kiuru A (2007) Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Drug Saf 30:515–525CrossRefPubMed
26.
go back to reference Colman E, Szarfman A, Wyeth J et al (2008) An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA’s spontaneous adverse event reporting system. Pharmacoepidemiol Drug Saf 17:1068–1076. doi:10.1002/pds.1643 CrossRefPubMed Colman E, Szarfman A, Wyeth J et al (2008) An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA’s spontaneous adverse event reporting system. Pharmacoepidemiol Drug Saf 17:1068–1076. doi:10.​1002/​pds.​1643 CrossRefPubMed
33.
go back to reference Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613–617. doi:10.1007/s00415-010-5805-z CrossRefPubMed Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613–617. doi:10.​1007/​s00415-010-5805-z CrossRefPubMed
35.
go back to reference Chio A, Benzi G, Dossena M, Mutani R, Mora G (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472–476CrossRefPubMed Chio A, Benzi G, Dossena M, Mutani R, Mora G (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472–476CrossRefPubMed
39.
go back to reference Bender R, Lange S (2001) Adjusting for multiple testing––when and how? J Clin Epidemiol 54:343–349CrossRefPubMed Bender R, Lange S (2001) Adjusting for multiple testing––when and how? J Clin Epidemiol 54:343–349CrossRefPubMed
Metadata
Title
Prior medical conditions and the risk of amyotrophic lateral sclerosis
Authors
Meinie Seelen
Perry T. C. van Doormaal
Anne E. Visser
Mark H. B. Huisman
Margot H. J. Roozekrans
Sonja W. de Jong
Anneke J. van der Kooi
Marianne de Visser
Nicol C. Voermans
Jan H. Veldink
Leonard H. van den Berg
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 10/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7445-1

Other articles of this Issue 10/2014

Journal of Neurology 10/2014 Go to the issue